Home
In this Webinar recording Dr Kathy Rainbird (Australian Digital Health Agency) and Dr William Smith (Clinical immunology/allergy specialist) explain how clinical immunology/allergy specialists can make the most of My Health Record in their clinical practice.
The Webinar took place on 16 June 2020 as part of a National Allergy Strategy Project to encourage more specialists to use My Health Record.
The National Allergy Strategy welcomes the Walking the allergy tightrope report tabled today by Trent Zimmerman, chair of the committee which conducted a parliamentary inquiry into allergies and anaphylaxis. The National Allergy Strategy also acknowledges the support provided by the Hon Greg Hunt, Minister for Health in progressing the inquiry.
Walking the allergy tightrope - Addressing the rise of allergies and anaphylaxis in Australia1.15 MB
“We would like to thank the parliamentary inquiry committee for what has been a very thorough and considered inquiry into the impact of allergic diseases,” said Dr Preeti Joshi, Co-chair of the National Allergy Strategy. “It was clear from the way the hearings were conducted that this Committee wanted to identify and understand all the important issues,” Dr Joshi said.
The National Allergy Strategy specifically welcomes recommendations regarding the establishment of an anaphylaxis register, additional allergy research, consideration of a healthcare card for allergic consumers, national standardisation of emergency department discharge after anaphylaxis admissions, minimum standards for allergy training for health professionals, improved training for food service, improved access to food and drug challenges, and improvement and expediating of food labelling.
It is also encouraging that the Committee recognises the importance of the National Allergy Strategy, Allergy & Anaphylaxis Australia (A&AA) and Australasian Society of Clinical Immunology and Allergy (ASCIA), as key organisations providing expertise and support to the community. We hope that ongoing sufficient funding will continue to support the important work each organisation undertakes.
“The National Allergy Strategy, is a partnership between the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia, the peak medical and patient support organisations for Australia and this is a key strength of the Strategy,” Ms Said, Co-chair of the National Allergy Strategy stated. “We are able to put consumers at the centre of everything we do with the support of the peak medical body and other key stakeholder organisations,” she said.
In 2015, the National Allergy Strategy was launched with the support of key stakeholder organisations who worked together to develop a blueprint for what needed improving and how it could be achieved. The recommendations tabled today address many of the key issues that the National Allergy Strategy believes are important to improving the management of allergic diseases in Australia.
Healthdirect Australia have asked the National Allergy Strategy to share the COVID‑19 Symptom Checker they have developed for people that are unwell and think they may have COVID‑19.
As medical staff, testing clinics and the National Coronavirus Helpline are overwhelmed with enquiries, the symptom checker can help alleviate pressure.
The COVID‑19 Symptom Checker provides people with advice on whether medical help is required and what they should do next, such as calling ahead before a visit to a GP or emergency department.
Access to the COVID‑19 Symptom Checker is available from the National Allergy Strategy website: www.nationalallergystrategy.org.au
The Australasian Society of Clinical Immunology and Allergy (ASCIA) has developed information and guidance regarding COVID-19.
The information is available on the ASCIA website at
www.allergy.org.au/about-ascia/info-updates/ascia-information-about-covid-19
The Australasian Society of Clinical Immunology and Allergy (ASCIA) through the National Allergy Strategy is collaborating with the Australian Digital Health Agency to provide information to clinical immunology/allergy specialists about using My Health Record to improve patient care.
This new Fact sheet for clinical immunology/allergy specialists developed by the National Allergy Strategy includes information about:
MHR Fact Sheet for Clinical Immunology/Allergy specialists208.13 KB
Additional resources designed to support your use of My Health Record in clinical practice are being developed as part of this project and will be released once complete.
Read more: Using My Health Record: Fact sheet for clinical immunology/allergy specialists
Understanding how to register and upload to My Health Record can be challenging. Join Professor Steven Boyages as he interviews Carey Doolan from the Australian Digital Health Agency to provide practical advice to help you register and upload to My Health Record. To register for this webinar on 4th March 2020, 6-7pm AEDT go to here.
For information about how the National Allergy Strategy is working with the Australian Digital Health Agency to improve the quality of patient allergy information in My Health Record go to NAS - Digital Health Agency
Read more: Register for the My Health Record Webinar – Wednesday 4 March 6pm -7pm AEDT
The National Allergy Strategy was pleased to be invited to speak at the public hearing of the parliamentary inquiry into allergy and anaphylaxis, in Sydney on the 19th November 2019. ASCIA and Allergy & Anaphylaxis Australia were also invited to speak at the hearing.
We would once again, like to acknowledge Mr Trent Zimmerman and Minister Hunt for their support of Australians living with allergic diseases by conducting this inquiry.
Pictured from: left Dr Preeti Joshi, Ms Karen Wong (back) Ms Maria Said, Mr Trent Zimmerman, Dr Mike Freelander, Ms Sandra Vale, Dr Brynn Wainstein, Ms Jody Aiken and Ms Jill Smith
Read more: Parliamentary inquiry into allergy and anaphylaxis
12 November 2019:The National Allergy Strategy would like to acknowledge Mr Trent Zimmerman and Minister Greg Hunt for conducting a federal parliamentary inquiry into allergies and anaphylaxis.
The National Allergy Strategy has made a submission to the parliamentary inquiry into allergies and anaphylaxis.
Download here: NAS Allergy Parliamentary Inquiry Submission490.12 KB
For further information about the parliamentary inquiry and how to make a submission, please access the following link: About the inquiry
12 September 2019: It is our pleasure to inform you that Mr Trent Zimmerman has announced a parliamentary inquiry into allergic diseases. The parliamentary inquiry will be undertaken by the Standing Committee on Health and will provide the opportunity for a thorough investigation into the many issues regarding the management of allergic diseases in Australia.
The National Allergy Strategy would like to acknowledge both Mr Trent Zimmerman and Minister Greg Hunt for their commitment to undertake the parliamentary inquiry and for their ongoing support of Australians living with allergic diseases.
Further information is available from:
New Parliamentary Inquiry: Allergies and anaphylaxis under the microscope 153.69 KBAllergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers.
healthdirect:
trusted health information
Funded by the governments of Australia
Australasian Society of Clinical Immunology and Allergy (ASCIA) is the leading medical organisation for allergy in Australia.
Allergy & Anaphylaxis Australia (A&AA) is the leading patient support organisation for allergy in Australia.
The National Allergy Strategy has received funding from the Australian Government Department of Health for the following projects:
Food allergy prevention | 250K Youth Project | Food service | Drug allergy | Shared Care Model
© National Allergy Strategy Aug 2015 | Contact Us | Disclaimer | Privacy | Sitemap
